Parasoft Logo

Embedded Software Testing for Medical Devices

By Ricardo Camacho January 16, 2026 9 min read

Explore the unique challenges of testing medical device software on resource-constrained hardware. Our guide offers actionable strategies to ensure patient safety while accelerating development timelines.

Embedded Software Testing for Medical Devices

By Ricardo Camacho January 16, 2026 9 min read

Explore the unique challenges of testing medical device software on resource-constrained hardware. Our guide offers actionable strategies to ensure patient safety while accelerating development timelines.

Medical device software failures can have devastating consequences, from insulin pump malfunctions to pacemaker timing errors that directly threaten patient lives.

As embedded systems become increasingly complex in medical devices, rigorous automated testing has evolved from best practice to a de facto regulatory expectation for managing complexity, risk, and compliance evidence.

With software-related issues driving a significant percentage of medical device recalls, organizations developing life-saving technologies face mounting pressure to deliver highly reliable embedded software with demonstrable risk control while navigating stringent FDA and IEC 62304 compliance requirements.

This guide examines the critical role of embedded software testing in medical device development, explores the unique challenges of testing resource-constrained systems with real-time requirements, and provides actionable strategies for implementing comprehensive testing approaches that protect patients while accelerating time to market.

Parasoft’s embedded software testing solutions address the full spectrum of testing challenges in resource-constrained environments, while specialized medical device software testing and validation capabilities ensure compliance with FDA expectations and IEC 62304 requirements.

Key Takeaways

  • Embedded software testing validates firmware on dedicated hardware with limited resources and real-time constraints, which is critical for medical device safety and regulatory submissions to the FDA.
  • Patient safety failures in medical devices can result in recalls, lawsuits, and fatalities, making rigorous testing non-negotiable for life-critical systems.
  • Regulatory compliance with IEC 62304, ISO 14971, and FDA guidance requires risk-based testing, complete traceability, and documented validation.
  • Medical embedded systems span monitoring devices (Class II/III), diagnostic systems requiring algorithm validation, and therapeutic devices (Class III) with the highest safety criticality.
  • Best practices include risk-driven testing aligned with ISO 14971, security risk management and verification activities aligned with ISO/AWI 81001-5-2, complete requirements traceability, early hardware-software integration, and comprehensive safety-critical behavior verification.
  • Automation reduces testing time and costs while ensuring consistent coverage and compliance with regulatory standards throughout the device life cycle.

What Is Embedded Software Testing?

Embedded software testing validates firmware running on dedicated hardware with limited resources and strict real-time requirements. Unlike general software testing, embedded testing must account for:

  • Severe resource constraints (memory, processing power, physical size)
  • Hardware dependencies including sensors and actuators
  • Timing criticality where microsecond delays can prove fatal
  • Debugging difficulty without traditional development tools
  • Medical devices exemplify these challenges perfectly.

Embedded systems operate within strict physical, power, and timing constraints that distinguish them from conventional software environments. Testing must validate:

  • Implantable neurostimulator pulse algorithms that deliver therapy with microsecond precision
  • Medical imaging system reconstructions that require flawless mathematical accuracy across all operational modes
  • Anesthesia delivery control systems that respond instantly to dynamic patient parameters

The specialized nature of these environments demands testing approaches specifically designed for hardware-dependent code, real-time operating systems, and resource-limited platforms.

A comprehensive guide to automated testing for embedded systems provides the foundational knowledge teams need to implement effective validation strategies that address these unique constraints while maintaining development velocity.

Why Are Embedded Systems in Medical Devices Important?

Embedded systems in medical devices carry unique importance across three critical dimensions.

1. Patient Safety

Patient safety represents the paramount concern. Software defects in medical devices create direct life-or-death scenarios. Real-world recalls illustrate this reality.

  • Medtronic insulin pumps experiencing dosage calculation errors.
  • St. Jude pacemakers vulnerable to cybersecurity exploits.
  • Numerous other cases where embedded software failures endangered patients.

A single coding error can cascade into catastrophic outcomes when embedded systems control drug delivery, cardiac rhythm, or respiratory support.

2. Regulatory Compliance

Regulatory compliance demands comprehensive validation. The FDA requires documentation verification and validation evidence for 510(k) clearance and PMA approval. IEC 62304 classifies medical device software into Class A, B, or C based on risk levels, with Class C devices (highest risk) requiring the most extensive testing and documentation.

Understanding how to streamline IEC 62304 compliance through automated testing and traceability tools dramatically reduces the documentation burden while ensuring all regulatory requirements are met.

Organizations must implement systematic risk management throughout the device life cycle using ISO 14971 as the primary management framework with IEC 62304—linking software safety classification to testing rigor. ISO 14971 mandates this risk-based approach, while FDA cybersecurity guidance now requires manufacturers to address security vulnerabilities proactively throughout the product life cycle.

3. Business Impact

Business impact extends beyond immediate patient safety to organizational viability.

  • Recall costs frequently exceed millions in direct expenses, legal liability, and remediation efforts.
  • Lawsuits from device failures create devastating financial and reputational damage.
  • Time-to-market delays compound costs as competitive advantages erode.
  • Reputation damage proves difficult to quantify but affects market position for years following high-profile failures.

What Are the Types of Embedded Systems in Medical Devices?

Medical devices employ different embedded system types, each presenting distinct testing challenges and regulatory classifications. Modern devices often integrate multiple functions, combining monitoring, diagnostic, and therapeutic capabilities in increasingly sophisticated ways.

Monitoring Embedded Systems

Monitoring systems continuously collect and display physiological data, typically classified as FDA Class II or III devices. Examples include pulse oximeters measuring blood oxygen saturation, ECG monitors tracking cardiac electrical activity, continuous glucose monitors (CGMs) providing real-time blood sugar readings, ICU patient monitoring systems integrating multiple vital signs, and blood pressure monitors.

Testing focuses on:

  • Sensor accuracy across physiological ranges
  • Alarm threshold reliability to prevent false positives and dangerous false negatives
  • Display reliability for critical information presentation
  • Communication protocol integrity for data transmission
  • Battery life validation for continuous operation
  • Data integrity throughout collection and storage

Key challenges include:

  • Electromagnetic interference (EMI) and radio frequency interference (RFI) can corrupt sensor readings.
  • Motion artifacts that introduce noise into measurements.
  • Real-time sampling requirements that demand precise timing.
  • Compliance with IEC 60601-1-8 alarm standards that specify alarm signals and priorities.

Diagnostic Embedded Systems

Diagnostic systems analyze physiological data to inform clinical decisions with accuracy. This is paramount because misdiagnosis directly harms patients. Examples include:

  • MRI and CT scanners that generate detailed anatomical images.
  • Clinical laboratory analyzers that process blood and tissue samples.
  • AI-powered diagnostic tools that identify patterns in medical images.
  • Digital pathology systems that analyze tissue samples.
  • Cardiac stress test systems that evaluate heart function under exercise conditions.

Testing emphasizes algorithm validation against large, validated datasets representing diverse patient populations, sensitivity and specificity metrics to quantify diagnostic accuracy, edge case handling for unusual presentations, calibration procedures ensuring measurement accuracy, clinical validation studies demonstrating real-world effectiveness, and AI/ML model testing following FDA software as a medical device (SaMD) guidance.

AI diagnostic systems require particularly rigorous validation, including diverse training datasets representing different demographics, continuous monitoring for model drift as data distributions change, and explainability mechanisms allowing clinicians to understand diagnostic reasoning.

Both compile-time and runtime validation prove essential for medical device software quality. Implementing static and dynamic analysis best practices in medical software ensures comprehensive defect detection at every development stage, catching coding standard violations, security vulnerabilities, and potential runtime errors before they reach patients.

Challenges include:

  • AI model validation with sufficient statistical power
  • Result reproducibility across different devices and operators
  • Large dataset management for training and validation

Therapeutic & Control Embedded Systems

Therapeutic and control systems represent the highest-risk category, directly delivering treatment or controlling critical physiological functions. Typically classified as FDA Class III and IEC 62304 Class C devices, failures result in immediate patient harm or death. Examples include:

  • Implantable neurostimulators for deep brain stimulation or pain management.
  • Automated external defibrillators (AEDs) that analyze and treat cardiac arrhythmias.
  • Heart-lung bypass machines controlling oxygenation and circulation during surgery.
  • Surgical robots performing precise movements during procedures.
  • Radiation therapy systems delivering targeted cancer treatment.
  • Anesthesia workstations that continuously monitor and adjust gas delivery.

Testing focuses on:

  • Real-time control algorithm validation under all operating conditions
  • Failsafe mechanism verification ensuring safe states during malfunctions
  • Fault detection capabilities identifying hardware and software errors
  • Boundary condition testing at maximum and minimum dosages or rates
  • Timing precision verification measuring response times
  • Hardware-in-the-loop (HIL) testing with actual hardware components
  • Safety interlock validation preventing dangerous operating conditions
  • Battery management for implantable devices
  • Cybersecurity validation protecting against unauthorized access

The Therac-25 radiation therapy accidents serve as historical reminders of catastrophic embedded software failures, where software race conditions led to massive radiation overdoses and patient deaths. Modern therapeutic devices must demonstrate reliability of 10 years or more for implantable systems, undergo extensive physiological simulation to model patient responses, and meet the highest testing standards. Testing challenges include:

  • Validating implantable devices without patient risk.
  • Ensuring reliability over extended operational lifetimes.
  • Accurately simulating complex physiological responses to therapy.

Best Practices for Testing Embedded Systems in Medical Devices

Effective medical device testing balances thoroughness, efficiency, and regulatory compliance. Best practices emerge from FDA guidance, IEC 62304 and ISO 14971 standards, and industry lessons learned from both successes and failures.

Use a Risk-Driven Testing Approach (ISO 14971)

ISO 14971 mandates risk-based testing prioritization that focuses resources on the most critical safety concerns. The process involves:

  • Identifying potential hazards through failure mode analysis and hazard analysis.
  • Estimating risk by calculating probability × severity for each identified hazard.
  • Determining IEC 62304 software safety class (A, B, or C) based on risk assessment.
  • Defining testing rigor accordingly.

For example, drug dosage calculation algorithms typically warrant Class C classification, requiring 100% code coverage, extensive boundary condition testing, and rigorous validation.

Conversely, noncritical user interface elements may receive Class A designation with basic functional validation sufficient. Risk-driven approaches ensure testing efforts align with actual patient safety impact rather than treating all code equally.

Traceability from identified risks through requirements to test cases provides auditable evidence that all hazards receive appropriate mitigation. Risk matrices visually communicate priorities, helping teams allocate testing resources effectively.

Use a Security-Driven Testing Approach (ISO/AWI 81001-5)

ISO/AWI 81001-5-2 addresses requirements and guidance for managing security risks throughout the life cycle of medical devices and health IT systems, specifically from design through production and into post-production, within a risk-management framework aligned with ISO 14971 (the medical device risk management standard).

Security testing serves as verification of implemented security risk controls rather than a standalone activity, ensuring that identified threats and vulnerabilities are effectively mitigated throughout the product lifecycle.

Here’s the process:

  1. Identify assets, threats, vulnerabilities, and related risks.
  2. Estimate and evaluate security risk levels.
  3. Select, implement, verify, and monitor security risk controls.
  4. Integrate security processes into design, production, and post-production activities.
  5. Coordinate with healthcare delivery organizations (HDOs) on risks and vulnerability disclosure/patching.
  6. Establish enterprise-wide processes for post-production security interactions.

For example, an embedded infusion pump that administers medication based on programmed parameters and exchanges data with hospital information systems presents a significant security risk due to its direct impact on patient safety and its network connectivity. Security risk management must address threats such as unauthorized access, manipulation of dosage parameters, and compromise of firmware integrity through controls including authentication, data integrity checks, secure communications, and controlled update mechanisms.

In contrast, a standalone embedded medical module with no external interfaces may present a reduced attack surface but still requires proportionate security controls based on intended use and potential harm. Identified security risks should be traceable to specific security requirements and verified through validation activities, ensuring comprehensive coverage of all relevant assets, attack surfaces, and threat scenarios.

Ensure Complete Requirements Traceability (IEC 62304)

IEC 62304 mandates bidirectional traceability, establishing clear relationships:

system requirements ↔ software requirements ↔ design ↔ code ↔ test cases ↔ test results

This traceability:

  • Proves complete coverage for regulatory audits.
  • Enables impact analysis when requirements change.
  • Satisfies rigorous regulatory scrutiny.

Manual traceability maintenance becomes impractical as medical device software grows in complexity, with thousands of requirements, design elements, code modules, and test cases requiring linkage.

Automated traceability solutions eliminate manual overhead while providing real-time visibility into coverage gaps, impact analysis for change requests, and audit-ready documentation that connects every line of safety-critical code back to its originating requirement and forward to its validation evidence.

Implementation requires traceability matrices or application lifecycle management (ALM) tools that maintain these linkages automatically, reducing the burden on development teams while ensuring no requirement goes untested.

Common gaps include orphaned requirements without associated tests, test cases lacking requirement links making their purpose unclear, and outdated traces following requirement changes. Regular traceability audits identify and resolve these inconsistencies before they become compliance issues during regulatory submissions.

Test Hardware-Software Integration Early

Testing software with actual hardware or high-fidelity simulators early in development proves critical for embedded medical devices. Issues surface during integration that cannot be detected in isolation:

  • Timing problems where operations miss critical deadlines.
  • Interrupt handling errors causing system instability.
  • Hardware interface mismatches preventing proper sensor readings.
  • Memory constraint violations leading to crashes.
  • Power consumption exceeding specifications.
  • Sensor calibration discrepancies affecting measurement accuracy.

Hardware-in-the-loop (HIL) testing, early development boards, and hardware simulators enable a shift-left testing philosophy, which doesn’t wait for final hardware availability.

For example, simulation might indicate software passes all functional requirements, but actual hardware reveals timing issues causing ventilator alarm delays of several hundred milliseconds, potentially fatal for critically ill patients.

Validate Reliability Through Real-World & Fault Conditions

Testing beyond "happy path" scenarios ensures devices perform reliably under adverse conditions patients will inevitably encounter. Real-world conditions include temperature extremes (storage and operating ranges), humidity exposure, electromagnetic interference from hospital equipment, low battery operation, network interruptions disrupting connectivity, sensor failures, and user errors including incorrect operation.

Testing approaches include:

  • Environmental testing in climate chambers and EMI/RFI chambers
  • Fault injection simulating sensor failures, memory errors, and communication disruptions
  • Long-duration testing running continuously for days or weeks to detect intermittent issues
  • Stress testing with boundary conditions at physiological extremes

Fault handling proves as critical as normal operation. Devices must detect failures, enter safe states, alert users appropriately, and maintain patient safety despite component malfunctions.

For example, insulin pumps must reliably detect occluded infusion lines that prevent drug delivery and trigger appropriate alarms, preventing dangerous hypoglycemia from missed doses.

Verify Safety-Critical Behavior

Medical device software must reliably perform critical functions under all conditions. Testing approaches include:

  • Validating fault detection and handling mechanisms.
  • Verifying failure mode responses including graceful degradation.
  • Testing alarm functionality for appropriate triggers and escalation.
  • Confirming error recovery procedures.
  • Validating system state management across transitions.
  • Ensuring critical path validation for life-safety functions.

Tools such as fault injection frameworks, failure mode simulators, and state machine analyzers systematically verify safety-critical behavior. For example, pacemakers must maintain safe backup pacing mode if primary sensing fails, and infusion pumps must trigger appropriate alarms when detecting occlusions or air bubbles in fluid lines.

Regulatory standards expect strong objective evidence of structural coverage structural coverage metrics for safety-critical medical device software with IEC 62304 Class C devices typically requiring 100% statement, branch and modified condition/decision coverage as minimum thresholds.

Organizations must achieve required code coverage targets. Using automated tools, systematic unit and integration testing objectively measure which code paths were exercised during validation. The resulting coverage metrics provide quantifiable evidence that all safety-critical functionality has been tested, identifying untested code that could harbor latent defects.

Get Started With Embedded Software Testing Using Parasoft

Embedded medical device testing presents unique challenges balancing patient safety, regulatory compliance, and development efficiency. Specialized testing approaches address resource constraints, real-time requirements, and hardware-software integration complexities while meeting stringent FDA and IEC 62304 standards.

Parasoft provides integrated automated testing solutions specifically designed for embedded medical device development. Static analysis, dynamic testing, and structural coverage capabilities work together to identify defects across the development life cycle.

Parasoft C/C++test delivers comprehensive analysis for embedded C/C++ applications. It identifies security vulnerabilities and safety defects early in development while supporting compliance with standards including CERT C/C++, MISRA C/C++, and IEC 62304. The unified toolset eliminates gaps between different testing phases, providing consistent quality enforcement from initial coding through final validation.

Organizations developing medical devices face complex regulatory requirements spanning functional safety, cybersecurity, and quality management standards. Parasoft’s compliance testing solutions support safety and security standards across the medical device life cycle, including IEC 62304, ISO 14971, ISO 81001-5-1 and ISO 81001-5-2, and FDA guidance with automated traceability connecting requirements through implementation to test results.

This comprehensive approach provides auditable evidence for certification submissions, dramatically reducing the documentation burden while ensuring all regulatory obligations are met.

Parasoft SOAtest automates API testing, moving beyond unit and component-level checks. It validates the security of communication channels and data exchanges between embedded system components and connected enterprise or cloud services, which are common attack vectors in modern medical devices with network connectivity.

Accelerate your medical device testing while ensuring patient safety and regulatory compliance.

Request a Demo